Literature DB >> 1442246

Oral contraception noncompliance: the extent of the problem.

P J Hillard1.   

Abstract

Compliance has been defined as the extent to which a patient's behavior coincides with the clinical prescription. The lowest expected failure rate of oral contraceptive (OC) use has been suggested to be 0.1%; however, in typical users, the failure rate varies by age, race, and marital status. In some populations in the United States (eg, unmarried black adolescents), the failure rate is 18%; rates that factor in the occurrence of abortions suggest an overall failure rate of 6.2% during the first year of use. If the annual failure rate of 6.2% is assumed, long-term failure rates rapidly approach 25% to 50% (ie, the proportion of users who will experience an unintended pregnancy) over 10 years of use. The gap between the lowest expected failure rate and the failure rates seen in typical users is related in large part to problems of compliance. Compliance with OC use includes both correct daily use and continuing use. Factors that contribute to OC discontinuation include the experience of side effects, fears and misinformation about OC side effects fueled by negative media reports, and intermittent use. There are relatively few data regarding the issue of missed pills and correct use, but studies suggest that adolescents may miss an average of 3 pills a month, and at least 20% to 30% of individuals miss a pill every month. Patients may have difficulty in the transition from one packet of pills to the next, and missed pills that extend the hormone-free interval may contribute to the failure rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442246     DOI: 10.1007/bf01849447

Source DB:  PubMed          Journal:  Adv Contracept        ISSN: 0267-4874


  9 in total

Review 1.  Prescribing oral contraceptives.

Authors:  E Weisberg
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

Review 2.  [Oral contraception--benefits and risks].

Authors:  W Braendle
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 3.  Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.

Authors:  M I Wilde; J A Balfour
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 4.  Biphasic versus monophasic oral contraceptives for contraception.

Authors:  H A A M Van Vliet; D A Grimes; F M Helmerhorst; K F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Should oral contraceptives be available without prescription?

Authors:  J Trussell; F Stewart; M Potts; F Guest; C Ellertson
Journal:  Am J Public Health       Date:  1993-08       Impact factor: 9.308

Review 6.  Biphasic versus triphasic oral contraceptives for contraception.

Authors:  H A A M Van Vliet; D A Grimes; F M Helmerhorst; K F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

7.  Imbalanced Nutrient Intake in Cancer Survivors from the Examination from the Nationwide Health Examination Center-Based Cohort.

Authors:  Boyoung Park; Jinhee Lee; Jeongseon Kim
Journal:  Nutrients       Date:  2018-02-14       Impact factor: 5.717

8.  Contraceptive method at first sexual intercourse and subsequent pregnancy risk: findings from a secondary analysis of 16-year-old girls from the RIPPLE and SHARE studies.

Authors:  Alison Parkes; Daniel Wight; Marion Henderson; Judith Stephenson; Vicki Strange
Journal:  J Adolesc Health       Date:  2008-10-18       Impact factor: 5.012

9.  Effectiveness and acceptability of progestogens in combined oral contraceptives - a systematic review.

Authors:  Regina Kulier; Frans M Helmerhorst; Nandita Maitra; A Metin Gülmezoglu
Journal:  Reprod Health       Date:  2004-06-03       Impact factor: 3.223

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.